Markets › Stocks › KIMIABL
KI

Kimia Biosciences Ltd

NSE: KIMIABLBSE: 530313Healthcare
₹33.75
▲ +2.27%
NSE · 15-min delayed
Mkt Cap
₹17 Cr
P / E
22.3
P / B
1.0
ROE
41.9%
52W High
₹86.85
52W Low
₹23.20
Key Metrics
Market Cap
₹17 Cr
P / E
22.3
P / B
1.0
ROCE
22.9%
ROE
41.9%
Div Yield
-
Revenue · ₹ Cr
106
FY20
133
FY21
125
FY22
129
FY23
105
FY24
119
FY25
115
FY26
Net Profit · ₹ Cr
1
FY20
5
FY21
-4
FY22
-9
FY23
-5
FY24
10
FY25
7
FY26
EPS · ₹ per share
₹0.3
FY20
₹1.1
FY21
₹-0.8
FY22
₹-2.0
FY23
₹-1.1
FY24
₹2.0
FY25
₹1.6
FY26
Q1 2026 snapshot
Sales
₹28 Cr
Operating profit
-
OPM
-
Net profit
₹0 Cr
EPS
₹0.15
Scorecard · 7 axes
Quality
Strong
78/100
Valuation
Good
22.3×
Growth
Avg
+7.9%
Profitability
Strong
32.4%
Performance
Bad
-30.8%
Entry Point
Strong
39%
Red Flags
Avg
1 flag
Shareholding Pattern
74.9%Promoter
Promoter74.9%
DII0.4%
Public24.7%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue30.5238.6924.4333.6730.228.21
Net Profit4.571.9920.6041.0155.4420.373
NPM %15.0%5.1%2.5%3.0%18.0%1.3%
AlertPre-trade